Coronary spasm is an accepted cause of transient myocardial ischemia in patients with variant angina; more recently it has been suggested that dynamic stenoses could also play an important role in the pathophysiology of exertional angina. To test this hypothesis we submitted 31 patients with histories typical of exertional angina to ergonovine testing and compared the electrocardiographic and clinical responses to those observed in seven patients with variant angina. All underwent bicycle ergometric exercise testing and coronary angiographic examination. For all tests, ST segment shifts of 0.1 mV or greater were considered to be diagnostic of myocardial ischemia. In patients with exertional angina, exercise testing produced diagnostic ST segment depression in 21 (68%). Ergonovine testing produced diagnostic ST segment depression in nine (29%). All nine had positive exercise test results and twoor three-vessel disease, yet the test was negative in seven other patients with positive exercise test results and similar angiographic findings. Conversely, in the seven patients with variant angina, results of exercise testing were positive in five (ST segment depression in two, ST elevation in three), while ergonovine produced ST segment elevation in all seven. Coronary angiographic examination showed normal arteries in two, one-vessel disease in four, and three-vessel disease in one. Results of all ergonovine tests were positive at values of rate pressure product much lower than those observed during exercise. Consequently it seems reasonable to postulate that in a sizable proportion of patients with exertional angina and diffuse coronary atherosclerosis, dynamic stenoses can contribute to produce ischemia, although the different electrocardiographic response to ergonovine testing suggests that the effects of vasoconstriction are less severe than those in variant angina.
ALTHOUGH fixed atherosclerotic obstructions are undoubtedly the cause of chronic stable angina, transient changes in caliber of coronary stenoses could play an important modulatory role in determining the frequency of symptoms.
Eccentric subintimal plaques can theoretically potentiate the effect of arterial smooth muscle contraction by acting as levers,' so that even minor degrees of constriction can cause dramatic changes in transtenotic resistance. Recent angiographic observations indicate that in an unselected group of patients, coronary stenoses can exhibit significant narrowing during handgrip exercises and significant dilatation after administration of nitroglycerin. 2' On the basis of these considerations, it seems possible that in patients with exertional angina, dynamic coronary stenoses could account for the variable exercise tolerance and for the occasional episodes of angina at rest often reported in their clinical histories. 4 We therefore submitted a group of patients with typical exertional angina to ergonovine testing, which is known to elicit constriction of epicardial coronary arteries,5 to evaluate their susceptibility to myocardial ischemia caused by dynamic stenoses. We also compared the clinical and electrocardiographic responses to ergonovine testing with those observed in a group of patients with active variant angina in whom coronary constriction is an accepted cause of ischemia.6
Materials and methods
Patients. We studied 31 patients with histories typical of exertional angina and seven patients with variant angina. They had a frequency of attacks ranging from five per week to three per day. We excluded patients with recent myocardial infarctions (less than 3 months), aortic stenoses, prior coronary revascularization, more than three attacks per day, attacks of long duration poorly responsive to nitroglycerin, and critical left main stem lesions. All gave written informed consent to participate in the study.
Exertional angina. The group comprised 31 patients (26 men, five women, ages 40 to 70 years, mean age 56 + 8); 20 patients also complained of angina at rest. Ten had histories of angina longer than 5 years, 13 longer than 1 year, and eight longer than 2 months; 18 patients had previous myocardial infarctions (table 1) .
Variant angina. The group comprised seven patients (six men, one woman, ages 47 to 59 years, mean age 53 + 3); they all had angina predominantly at rest with frequent nocturnal attacks. In all seven patients, standard 12-lead electrocardiograms recorded during pain documented the presence of transient episodes of ST segnient elevation. Coronary spasm was documented by angiographic examination in five patients. Two had histories of angina of more than 1 year, three of more than 2 months. Two patients had had previous myocardial infarctions.
Protocol. During hospitalization and after interruption of oral antianginal therapy for at least 24 hr, patients were submitted to exercise stress testing and coronary angiographic examination. Within a few days they underwent an ergonovine test in the catheterization laboratory under continuous monitoring of the standard 12-lead electrocardiogram and arterial pressure (brachial cannula). The test was interrupted at the onset of typical chest pain or of diagnostic ischemic electrocardiographic changes by the administration of amyl nitrate; this drug was selected because of its prompt pharmnacologic action; intravenous nitrates and calcium antagonists were available in case amyl nitrate was not quickly effective. Arterial pressure and electrograms from the 12 standard electrocardiographic leads were recorded on paper and on magnetic tape.
Methods. Exercise stress testing was performed on bicycle ergometer starting from 25 W with successive increments of 25 W every 2 min. Standard 12-lead electrocardiograms and blood pressure readings (cuff) were obtained every minute during the test and every 2 min during recovery. The test was continued until the onset of chest pain, diagnostic electrocardiographic changes, or exhaustion. Patients in whom the ischemic changes appeared at 75 W and/or at a heart rate lower than 120 beats/min (in the absence of /3-blockers) were considered to have a low exercise tolerance.
Ergonovine was administered in serial doses of 0.025, 0.05, 0.10, and 0.20 mg at intervals of 5 min.
For all tests the following electrocardiographic changes were considered to be diagnostic of ischemia: rectilinear or downsloping ST depression greater than 0.1 mV or ST segment elevation greater than 0.1 mV in leads-without pathologic Q waves. The reproduction of the usual anginal pain without diagnostic ST segment changes was considered separately. Coronary stenoses were considered clinically significant for reductions of 70% or greater in the internal lumen diameter.
Results
Exertional angina. Coronary angiographic findings showed absence of critical stenoses in two patients (6%), one-vessel disease in 10 (32%), two-vessel disease in 13 (42%), and three-vessel disease in six (20%) (table 1).
Results of exercise stress testing were positive in 21 patients (68%), 10 of whom had low tolerance (32%); M N ER LAD 30, C 90 N = normal; OAMI = old anterior myocardial infarction; OIMI = old inferior myocardial infarction; E = exertional angina only; ER = exertional and rest angina; LAD = left anterior descending coronary artery; R = right coronary artery; C = circumflex coronary artery.
APatients with positive response to ergonovine.
diagnostic ST segment ischemic changes were associated with anginal pain in 18 patients. The incidence of positive results of exercise stress tests was similar in patients with exertional angina only (73%, 36% with low tolerance) and in those who also reported angina at rest (65%, 30% with low tolerance) ( (table 3) . Nine patients (29%) had positive results of ergonovine testing (ST depression in all), seven of whom also developed typical chest pain; in all nine patients exercise test results were positive (seven with low tolerance), and all had stenoses of 70% or greater and twoor three-vessel disease. However, ergonovine failed to cause ischemic electrocardiographic changes and chest pain in seven patients with positive exercise test results (three with low tolerance) and twoor three-vessel disease. The test provoked ischemia in a higher percentage of patients who also reported angina at rest (35%) than in those with pure exertional angina (18%) (table 2). Ergonovine produced typical chest pain in the absence of diagnostic electrocardiographic changes in seven patients (23%); of these, three had positive exercise test results with high tolerance, two had chest pain only, and two had negative results. One of these patients had no critical stenoses, three had one-vessel disease, and three had two-vessel disease (table 3). The total dose of ergonovine that elicited diagnostic ischemic ST segment changes ranged from 0.05 to 0.375 mg (mean 0.23 0. 14). The dose that caused pain without diagnostic ST segment changes ranged from 0.175 to 0.375 mg (mean 0.315 ± 0.09). The patients who had a completely negative test received ergonovine doses up to 0.375 mg.
No complications were observed as a consequence DIAGNOSTIC METHODS-VASOSPASM of the ergonovine test in patients with severe coronary disease and markedly reduced coronary flow reserve; in particular, none of the severe disturbances commonly observed in variant angina or ischemia resistant to nitrates was seen in any of the patients during testing.
On the average, systolic blood pressure increased from 131 ± 18to 178 ± 15mmHg(p -.001)during exercise and from 149 ± 22 to 163 ± 28 mm Hg (p S .001) during the ergonovine tests. Heart rate increased from 80 ± 13 to 136 ± 22 mm Hg (p S .001) during exercise and from 72 ± 10 to 75 ± 10 mm Hg (p < .001) during the ergonovine tests. Basal systolic pressure was significantly lower before exercise testing than before ergonovine testing; this was probably because of the orthostatic position during exercise and possibly because of the underestimation of systolic blood pressure by cuff.
In patients with low exercise tolerance, the rate pressure product at the onset of electrocardiographic changes during the ergonovine test was significantly lower than that during exercise, both in each individual patient and in the group ( 11.720 ± 2.081 vs 18.288 ± 872 mm Hg . beats/min; p C .001); the changes in heart rate were even lower than those of the blood pressure. The behavior of the rate pressure product both before the tests and at the onset of electrocardiographic changes was similar in patients with similar angiographic findings and exercise tolerance but with negative responses to ergonovine (figure 1). Variant ease in four (in three of these the stenotic artery was filled retrogradely by visible collaterals), and threevessel disease in one. The exercise test precipitated ST segment elevation in three patients (normal arteries in one, one-vessel disease in two) and ST segment depression in two (one-vessel disease in one, three-vessel disease in the other); results of the test were negative in the remaining two patients (normal arteries in one, one-vessel disease in the other).
Results of the ergonovine test were positive in all seven patients with ST segment elevation (five of whom also had chest pain). The total dose that provoked the electrocardiographic changes ranged from 0.05 to 0.325 mg (mean 0.25 ± 0.09). Figure 2 shows the different incidence of positive responses to ergonovine and exercise tests in patients with exertional and variant angina. ST .
Discussion
As expected, exercise was the most effective test in provoking myocardial ischemia in patients with exertional angina, whereas ergonovine was the most effective in patients with variant angina. This obvious difference in response can be readily explained by the reduced coronary flow reserve consequent to atherosclerotic narrowings in exertional angina and by the supersensitivity of epicardial vessels to vasoconstrictor stimuli in patients with variant angina. However, our data indicate a wide overlap between this pattern of results in the two groups of patients. Exercise produced myocardial ischemia in about 70% of patients with variant angina and ergonovine caused ischemic ST segment changes in about 30% of patients with exertional angina.
Moreover, the number of patients with exertional angina in whom ergonovine produced ischemia would have been considerably higher if we had considered those patients in whom the test produced angina without diagnostic electrocardiographic changes as having positive results. The reproduction of their usual pain is likely to represent lesser degrees of ischemia not revealed by diagnostic electrocardiographic changes as suggested by preliminary observations.'
In patients with variant angina, ischemia can develop during exertion not only as a result of excessive increase of myocardial oxygen consumption but also as a result of coronary spasm, which has been observed both in apparently normal segments of coronary arteries and at the site of severe atherosclerotic stenoses. 8 9 On the other hand, Bertrand et al.'0 showed that after a dose of 0.4 mg of ergonovine vasospasm can be found in patients with exertional angina. These authors observed a change in coronary caliber that met their criteria for spasm in 4% of patients with only exertional angina and in 14% of those who also had angina at rest. Unfortunately, their findings are not comparable with ours because they did not mention the incidence of chest pain and ischemic ST segment changes after the test. Because of the curvilinear relationship between caliber and resistance to flow, it is quite possible that critical changes in lumen, particularly at the site of severe stenoses, might not be detectable by visual inspection of the arteriogram. In our patients the lack of angiographic documentation during the ergonovine test did not allow us to have direct proof of coronary vasoconstriction. However, since the changes in heart rate and systolic blood pressure observed after ergonovine were minimal, it seems reasonable to assume that in these patients the drug caused ischemia by transient impairment of blood flow rather than by increase of 694 myocardial oxygen consumption. All those who had positive results had severe coronary atherosclerosis and positive responses to exercise stress testing, indicating that only in the presence of a reduced coronary flow reserve is ergonovine able to provoke ischemia; yet the test was negative in other patients with similar angiographic findings and coronary reserve. A combination of a different proportion of eccentric and concentric stenoses and a different susceptibility to vasoconstriction can explain these results. In fact, postmortem observations show that only 70% of atherosclerotic stenoses are eccentric and with a wellpreserved smooth muscle so that vasoconstriction may take place." Moreover, in patients who do not develop spasm, the diffuse reduction in the diameter of coronary arteries produced by ergonovine varies from few percent to about 50% in some individuals.5 The higher incidence of responders in patients who also report angina at rest and a variable threshold of exertional angina supports the hypothesis that vasoconstriction is probably the cause of these symptoms.
While the positive response to ergonovine testing was always characterized by ST segment depression in patients with exertional angina, indicating the presence of subendocardial ischemia, it was always characterized by ST segment elevation (transmural ischemia) in patients with variant angina. The difference cannot be explained only by the presence of severe two-or three-vessel disease because ST segment elevation can be observed in similar patients with variant angina. 12 This finding suggests that in patients with exertional angina the response to ergonovine is characterized by a partial lumen reduction rather than by total vessel occlusion. In fact, in the presence of a severe coronary stricture, minimal reductions of the stenotic area can lead to a dramatic increase of the transtenotic gradient,'3 with reduction of poststenotic pressure resulting in subendocardial ischemia. 4 However, in theory subendocardial ischemia could also be provoked by a total occlusion of the vessel at the site of a critical stenosis in a territory perfused by collaterals.`The different electrocardiographic responses to ergonovine in our patients with variant angina is likely to be related to a transient total coronary occlusion, which does occur in both normal and stenotic arteries'6 but which in the last case is so severe as to prevent the possible supply of blood from collaterals. Therefore, as expected, the sensitivity of coronary smooth muscle cells to vasoconstrictor stimuli appears to be much greater in patients with variant angina than in those with exertional angina in whom the presence of multiple critical atherosclerotic stenoses is likely to be the necessary substrate for ergonovine-induced myocardial ischemia. This conclusion is also confirmed by the absence of complications during the test in patients with exertional angina as compared with the complications observed in patients with similar coronary anatomy but who have Prinzmetal's angina.'7
Conclusions
Our data show that a sizable proportion of patients with exertional angina, but not others with comparable atherosclerosis and reduction in exercise tolerance, can have ischemia provoked by coronary vasoconstriction. However, their sensitivity to ergonovine is much lower than that of patients with variant angina. This observation can have important therapeutical implications. Further investigations are needed to determine whether the mechanisms mediating coronary vasoconstriction in exertional and variant angina are similar or different, as suggested by the different responses to hyperventilation and the cold pressor test observed in patients with the two types of angina.'8
